Gainey McKenna & Egleston has announced the filing of a securities class action lawsuit against Inovio Pharmaceuticals, Inc. The lawsuit was filed in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or acquired Inovio securities between October 10, 2023, and December 26, 2025.
The legal action targets Inovio Pharmaceuticals, which is publicly traded on NASDAQ under the ticker INO. The complaint covers all individuals and entities involved in transactions during the specified period.
**Why this matters**
This lawsuit highlights potential concerns regarding the accuracy and transparency of information provided by Inovio Pharmaceuticals to its investors during the class period. The outcome may have implications for shareholders and the company’s future disclosures.
Source: NewsData